Genfit SA (GNFT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Europe

Author(s):

Product Code:GDPH58846D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

46

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company's pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program for auto-immune and inflammatory diseases; and TGFTX4 for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, liver diseases, non-alcoholic steatohepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. The company's research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA (GNFT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Genfit SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9

Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genfit SA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Genfit Enters into Agreement with Pinnacle Clinical Research Center 11

ImaBiotech Enters Into Agreement With Genfit 12

Equity Offering 13

Genfit Raises USD50 Million in Rights Offering of Shares 13

Genfit Raises USD38 Million Private Placement of Shares 14

Genfit Raises USD54.2 Million in Private Placement of Shares 15

Genfit Raises USD26 Million in Private Placement of Shares 16

Genfit Raises USD67.5 Million in Private Placement of Shares 17

Genfit Raises USD6.8 Million in Private Placement of Shares 18

Genfit Completes Private Placement Of Shares For USD 19 Million 19

Debt Offering 20

Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20

Acquisition 21

Novartis May Acquire Genfit 21

Genfit SA-Key Competitors 22

Genfit SA-Key Employees 23

Genfit SA-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Sep 24, 2018: GENFIT: 2018 Half-Year Results: Cash Position at End of Period at EUR238M and Significant Advances in the Clinical Development of Elafibranor 25

Apr 27, 2018: GENFIT: First quarter 2018 financial information 30

Oct 11, 2017: GENFIT: Third quarter 2017 financial information 31

Sep 25, 2017: Genfit: 2017 Half-Year Results: Cash Position At End Of Period At EUR126M And Significant Advances In The Company'S Pipeline 32

Apr 24, 2017: Genfit: Q1 2017 Financial Information 37

Corporate Communications 41

Sep 26, 2018: GENFIT: further details on management changes 41

Sep 24, 2018: GENFIT: Organizational Changes 42

Government and Public Interest 44

Apr 10, 2018: Vanderbilt scientists test potential new way to treat anemia 44

Product News 45

10/02/2017: GENFIT announces its participation at the 2017 AASLD Meeting 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List of Figure

List of Figures

Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genfit SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genfit SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9


List of Table

List of Tables

Genfit SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Genfit SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genfit SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genfit SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genfit SA, Deals By Therapy Area, 2012 to YTD 2018 8

Genfit SA, Medical Devices Deals, 2012 to YTD 2018 9

Genfit SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genfit Enters into Agreement with Pinnacle Clinical Research Center 11

ImaBiotech Enters Into Agreement With Genfit 12

Genfit Raises USD50 Million in Rights Offering of Shares 13

Genfit Raises USD38 Million Private Placement of Shares 14

Genfit Raises USD54.2 Million in Private Placement of Shares 15

Genfit Raises USD26 Million in Private Placement of Shares 16

Genfit Raises USD67.5 Million in Private Placement of Shares 17

Genfit Raises USD6.8 Million in Private Placement of Shares 18

Genfit Completes Private Placement Of Shares For USD 19 Million 19

Genfit Raises USD212 Million in Private Placement of 3.5% Bonds Due 2022 20

Novartis May Acquire Genfit 21

Genfit SA, Key Competitors 22

Genfit SA, Key Employees 23

Genfit SA, Subsidiaries 24

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022